Company / Cost of Revenue
CHAMPIONS ONCOLOGY, INC. Cost of Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$29.4M
FY2025
5-year range
$17.0M / $29.4M
FY2021-FY2025
Trend
+3.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has increased for 4 consecutive years, from $17M in FY2021 to $29M in FY2025.
Based on SEC 10-K filings.
$29M in FY2025 with a 5-year CAGR of +6.5%.
Increased from $24M to $29M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +11.1%
- 5-Year CAGR
- +6.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- CHAMPIONS ONCOLOGY, INC.'s cost of revenue has grown for 4 consecutive years.
- 5-year CAGR of +6.5%, indicating consistent growth.
- In FY2025, cost of revenue increased 3.6% year-over-year.
- Lowest cost of revenue in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.4M | +3.6% |
| FY2024 | $28.4M | +20.1% |
| FY2023 | $23.6M | +10.2% |
| FY2022 | $21.4M | +26.2% |
| FY2021 | $17.0M | -20.7% |
| FY2020 | $21.4M | +26.2% |
| FY2019 | $17.0M | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026